TalkMed CEO suspended for eight months
PROMINENT cancer specialist Ang Peng Tiam, who is the chief executive officer and main revenue contributor of Catalist-listed TalkMed Group, has been given an eight-month suspension by the Singapore Medical Council after a failed appeal against a misconduct conviction.
Dr Ang contributes over half of the revenue of the firm. He had originally appealed against his S$25,000 fine by the Singapore Medical Council.
TalkMed requested for a trading halt on Wednesday morning. Its shares last traded at S$0.745.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
China’s top airlines improve balance sheet in Q1; outlook positive for May Day
Stablecoin issuer Tether invests US$200 million in brain-computer interface company
Yahoo to lay off staff in Singapore as it shifts to content curation
US: Wall St opens higher on megacap strength, Fed verdict awaited
IReit Global occupancy rate grows to 91.5% in Q1
Yen surges against US dollar on suspected intervention